The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.

Eton has acquired the rights in the US to Amglidia for neonatal diabetes mellitus, from French biotechnology company AMMTeK.

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the ...

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Roche has signed an agreement to acquire Poseida Therapeutics in a $1.5bn deal. The transaction includes Poseida's clinical ...

The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer ...

PCI Pharma Services is a winner in the Innovation and Business Expansion categories in the 2024 Pharmaceutical Technology ...

Founded in 2017 as a spin-out from the University of Copenhagen and Rigshospitalet, Adcendo previously raised $102.8m (€98m) ...

The biopharmaceutical industry is being called to take its sustainability efforts to the next level. A new report sheds light ...

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.

On 5 November 2024, former US president Donald Trump was elected to a second term in the US presidential election.